Related Experiment Video
Updated: Jul 19, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Acute myocardial infarction
Eric Boersma1, Nestor Mercado, Don Poldermans
1Erasmus University Medical Center and Thoraxcenter, Department of Cardiology, Rotterdam, The Netherlands. h.boersma@erasmusmc.nl
Insights
Acute myocardial infarction (AMI) management has advanced, improving survival. Key challenges remain in widespread prevention and timely acute treatment for all high-risk individuals.
Area of Science:
- Cardiology
- Public Health
Background:
- Acute myocardial infarction (AMI) is a significant cause of mortality, morbidity, and healthcare costs.
- Coronary atherosclerosis is a primary underlying factor in many AMI cases.
- A revised definition of myocardial infarction impacts epidemiological and patient perspectives.
Purpose of the Study:
- To review the evolving landscape of acute myocardial infarction management.
- To highlight advancements in therapeutic approaches and their impact.
- To identify future challenges in prevention and treatment delivery.
Main Methods:
- Review of recent advancements in coronary-care units.
- Analysis of randomized clinical trial outcomes for reperfusion therapies (lytic and percutaneous coronary intervention).
- Evaluation of chronic medical treatments and pharmacological agents.
Main Results:
- Therapeutic approaches have substantially changed, reducing in-hospital mortality.
- Long-term outlook for AMI survivors has improved due to advanced treatments.
- New treatments continue to emerge, offering further therapeutic potential.
Conclusions:
- Effective implementation of preventive strategies for high-risk individuals is crucial.
- Expanding timely acute treatment delivery to all eligible patients is a major ongoing challenge.
- Continued innovation in treatments is expected, but focus must also be on accessibility and prevention.
Abstract:
Acute myocardial infarction is a common disease with serious consequences in mortality, morbidity, and cost to the society. Coronary atherosclerosis plays a pivotal part as the underlying substrate in many patients. In addition, a new definition of myocardial infarction has recently been introduced that has major implications from the epidemiological, societal, and patient points of view. The advent of coronary-care units and the results of randomised clinical trials on reperfusion therapy, lytic or percutaneous coronary intervention, and chronic medical treatment with various pharmacological agents have substantially changed the therapeutic approach, decreased in-hospital mortality, and improved the long-term outlook in survivors of the acute phase. New treatments will continue to emerge, but the greatest challenge will be to effectively implement preventive actions in all high-risk individuals and to expand delivery of acute treatment in a timely fashion for all eligible patients.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Introduction Cardiac Emergencies
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy

